Deal History
About us
Selskabet
Team
Vores kontorer
Globalscope
Worldwide
Canada
Denmark
France
Germany
Poland
Sweden
United Kingdom
USA
Services
Corporate Finance
Debt Advisory
Equity Research
Vækstkapital
IPO Strategi og forberedelse
Industrifokus
Business Services
Consumer / Retail / E-commerce
Industrials
Life Science og Healthcare
Software
Career
Events
Insights
News
Company news
Deal news
Carlsquare in the Media
Newsletter
Kontakt
Newsletter
DA
INT
DE
FR
SV
US
Main menu button
Team
Deals
Kontakt
Team
Deals
Kontakt
News
Alle
Company news
Deal News
Equity Research
Events
I Medier
Insights
Macro and markets
Alle
Abera Bioscience
All for One Group
ALM Equity
Alzecure Pharma
Angler Gaming
Arctic Minerals
Biosergen
Candles Scandinavia
Carlsquare
CDON
CellaVision
CSAM Health Group
Elicera Therapeutics
Enrad
Frequentis
Future Gaming
GHP Specialty Care
Hanza
Herantis Pharma
Immunovia
InCoax
Kancera
KlaraBo
Lohilo Foods
Lokotech
Medclair Invest
Midsummer
Modus Therapeutics
Moninvent
Nischer Properties
Nosa Plugs
Observit
Orion Corporation
Risk Intelligence
SBB i Norden
Spotlight Group
Svenska Aerogel
Teneo AI
Thinc Collective
Viva Wine Group
White Pearl Technology Group
Zinzino
Alle
04 okt 2024
Equity research, Zinzino: On track to achieve growth target
Equity Research
Zinzino
02 okt 2024
Carlsquare weekly market letter: China took the lead – what’s next?
Equity Research
Carlsquare
25 sep 2024
Carlsquare weekly market letter: Is China finally taking off?
Equity Research
Carlsquare
23 sep 2024
Carlsquare Equity Research interview with Biosergen
Equity Research
Biosergen
18 sep 2024
Carlsquare weekly market letter: Another leg down – or time for small caps?
Equity Research
Carlsquare
16 sep 2024
Carlsquare Equity Research: Swedish consumer sector snapshot
Equity Research
Viva Wine Group
12 sep 2024
Research update Biosergen: First patient treated in phase Ib study a success
Equity Research
Biosergen
11 sep 2024
Carlsquare weekly market letter: How to deal with a stormy market
Equity Research
Carlsquare
09 sep 2024
Equity Research Svenska Aerogel, Q2 2024: Low revenues, but important orders in place
Equity Research
Svenska Aerogel
05 sep 2024
Equity research Zinzino: Making a late summer splash
Equity Research
Zinzino
04 sep 2024
Carlsquare weekly market letter: Time for a new bump in the road?
Equity Research
Carlsquare
03 sep 2024
Equity Research Enrad Q2 2024: Enrad should invest in growing markets
Equity Research
Enrad
02 sep 2024
Equity research Zinzino: Robust profit growth despite lower gross margin in Q2 2024
Equity Research
Zinzino
30 aug 2024
Equity research Enrad, Q2 2024: Very strong quarter
Equity Research
Enrad
30 aug 2024
Equity research Zinzino: Profit growth despite pressure on gross margin in Q2 2024
Equity Research
Zinzino
29 aug 2024
Equity Research Svenska Aerogel, Q2 2024: Net revenues below expectations, but better profitability
Equity Research
Svenska Aerogel
29 aug 2024
Equity research Viva Wine Group: Profitability uptick ahead of expectations
Equity Research
Viva Wine Group
29 aug 2024
Equity research Nosa Plugs Q2, 2024: A second quarter with significant news flow
Equity Research
Nosa Plugs
28 aug 2024
Equity research Viva Wine Group: Return to strong EBITA growth in Q2 2024
Equity Research
Viva Wine Group
28 aug 2024
Carlsquare weekly market letter: Does the Fed know something we don't?
Equity Research
Carlsquare
1
…
10
11
12
13
14
…
64